Loading…

The Angiographic Fate of Infarct Related Arteries with TIMI 2 Flow Following Thrombolysis for Acute Myocardial Infarction

In the GUSTO Angiographic Trial 1,175 patients underwent angiography at a mean of 97±12 min following thrombolysis with either t-PA, Streptokinase, or a combination of both agents. For all treatment groups combined, 313 (27%) patients had TIMI 2 flow (T2). Of the patients with early TIMI 2 flow 151...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 1995-02, Vol.25 (2), p.60A-61A
Main Authors: Reiner, Jonathan S., Lundergan, Conor F., Fung, Anthony, Cho, Shyuan, Israel, Noah, Kazmierski, John, Pilcher, George, Smith, James, Rohrbeck, Steven, Thompson, Mark, Ross, Allan M.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the GUSTO Angiographic Trial 1,175 patients underwent angiography at a mean of 97±12 min following thrombolysis with either t-PA, Streptokinase, or a combination of both agents. For all treatment groups combined, 313 (27%) patients had TIMI 2 flow (T2). Of the patients with early TIMI 2 flow 151 (48%) continued to have TIMI 2 flow af follow-up (f/u) angiography a mean of 5.9±1.9 days later. while in 162 (52%) the flow had improved to TIMI 3. The plot on the left shows the minimum luminal diameter (MLD) for patients with TIMI 2 flow at 90 minutes and 5–7 day f/u vs those with TIMI [Display omitted] 2 flow at 90 minutes and TIMI 3 flow at f/u. The plot on the right shows the percentage of patients with angiographically visible thrombus at 90 minutes and f/u for patients with TIMI 2 flow at 90 minutes and 5–7 day f/u vs those with TIMI 2 flow at 90 minutes and TIMI 3 flow at f/u. Infarct related arteries that improve from TIMI 2 to TIMI 3 during the week following thrombolysis show a significant increase in minimal luminal diameter and decrease in visible thrombus compared with IRA:s that remain TIMI 2 suggesting that yet incomplete clot lysis explains the initial slow flow in this cohort.
ISSN:0735-1097
1558-3597
DOI:10.1016/0735-1097(95)91704-2